marbocyl bolus 50 mg tablet
vetoquinol uk ltd - marbofloxacin - tablet - antimicrobial - cattle
invanz
merck sharp & dohme b.v. - ertapenem sodium - community-acquired infections; streptococcal infections; staphylococcal infections; gram-negative bacterial infections; surgical wound infection; pneumonia, bacterial - antibacterials for systemic use, - treatmenttreatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required:intra-abdominal infections;community-acquired pneumonia;acute gynaecological infections;diabetic foot infections of the skin and soft tissue.preventioninvanz is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery.consideration should be given to official guidance on the appropriate use of antibacterial agents.
marbocyl bolus 50 mg tablet
vetoquinol ireland limited - marbofloxacin - bolus - 50 mg/tablet - marbofloxacin - cattle - antibacterial
augmentin tablets film-coated
smithkline beecham limited - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets film-coated - 500mg+ 125mg
augmentin tablets film-coated
smithkline beecham limited - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets film-coated - 875mg+ 125mg
augmentin tablets film-coated
smithkline beecham limited - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets film-coated - 250mg+ 125mg
augmentin powder for oral suspension
smithkline beecham limited - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - powder for oral suspension - 125mg/5ml+ 31,25mg/5ml
augmentin powder for oral suspension
smithkline beecham limited - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - powder for oral suspension - 250mg/5ml+ 62,5mg/5ml
augmentin powder for oral suspension with mixed fruit flavour
smithkline beecham limited - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - powder for oral suspension with mixed fruit flavour - 200mg/5ml+ 28,5mg/5ml
ceftazidime mylan
viatris limited - ceftazidime pentahydrate 1.164 g equivalent to 1 g ceftazidime; ; - powder for injection - 1 g - active: ceftazidime pentahydrate 1.164 g equivalent to 1 g ceftazidime excipient: sodium carbonate - indicated for the treatment of single and mixed infections caused by susceptible organisms. may be used alone as first choice medicine before the results of sensitivity tests are available. may be used in combination with an aminoglycoside or most other ?- lactam antibiotics. may be used with an antibiotic against anaerobes when the presence of bacteroides fragilis is suspected. susceptibility to ceftazidime will vary with geography and time and local susceptibility data should be consulted where available. indications include: severe infections: for example: - septicaemia, bacteraemia, peritonitis, meningitis. - infections in immunosuppressed patients. - infections in patients in intensive care, e.g. infected burns. - respiratory tract infections including lung infections in cystic fibrosis. - ear, nose and throat infections. - urinary tract infections. - skin and soft tissue infections. - gastrointestinal, biliary, and abdominal infections. - bone and joint infections. - infections associated with haemo- and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (capd)